Indivior PLC Ordinary Shares (INDV NASDAQ) stock market data APIs
$35.3838
-0.74(-2.1%)
as of December 5, 2025
Try our APIs with
free plan!
Indivior PLC Ordinary Shares Financial Data Overview
Price chart is built with
Anychart
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Prev. Close
35.3838
Open
34.6394
High
35.4674
Low
34.1091
52 wk Range
7.62-35.305
Market Cap
4 391 M
P/E Ratio
35.8367
Shares Outstanding
125 M
Revenue
1 180 M
EPS
0.72
Beta
1.109
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Indivior PLC Ordinary Shares (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Indivior PLC Ordinary Shares data using free add-ons & libraries
Get Indivior PLC Ordinary Shares Fundamental Data
Indivior PLC Ordinary Shares Fundamental data includes:
- Net Revenue: 1 180 M
- EBITDA: 324 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-30
- EPS/Forecast: 0.39
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Indivior PLC Ordinary Shares News
New
CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of tr...
The Remitly Reassessment: What Divisadero’s 95 Million Exit Tells Us About Digital Money Movement
Key Points Divested 5,036,343 shares of Remitly Global, resulting in a position value decrease of approximately $94.68 million The transaction represented a 3.94% change relative to the fund’s repo...
The Remitly Reassessment: What Divisadero’s 95 Million Exit Tells Us About Digital Money Movement
Key Points Divested 5,036,343 shares of Remitly Global, resulting in a position value decrease of approximately $94.68 million The transaction represented a 3.94% change relative to the fund’s repo...
FDA to remove “black box” warnings on hormone therapies for menopause
[FDA Headquarters - White Oak Campus] hapabapa Marking a pivotal moment in women’s health, the U.S. Food and Drug Administration (FDA) on Monday initiated actions to remove “black box” warnings...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
